StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
2697
This month
43
This week
10
This year
205
Today
5
Yesterday
7
Publishing Date
2024 - 04 - 24
5
2024 - 04 - 23
2
2024 - 04 - 22
3
2024 - 04 - 18
3
2024 - 04 - 17
2
2024 - 04 - 16
1
2024 - 04 - 15
3
2024 - 04 - 11
4
2024 - 04 - 10
1
2024 - 04 - 09
5
2024 - 04 - 08
3
2024 - 04 - 07
1
2024 - 04 - 06
1
2024 - 04 - 05
1
2024 - 04 - 04
2
2024 - 04 - 02
1
2024 - 04 - 01
5
Sector
Commercial services
1
Finance
1
Finance and insurance
1
Health services
2
Health technology
20
Manufacturing
4
N/a
4
Non-energy minerals
1
Professional, scientific, and technical services
6
Technology services
1
Tags
Acquisition
97
Agreement
109
Association
53
Biopharma
62
Business
136
Cancer
107
Cell
58
Ceo
54
Commercial
52
Company
118
Conference
592
Corporation
212
Deadline
90
Earnings
63
Energy
154
Events
55
Fda
61
Financial
687
First
1114
For
914
Global
158
Grants
64
Group
200
Growth
164
Health
94
International
88
Key
144
Management
84
Market
495
Medical
67
Meeting
238
Million
247
N/a
6070
Nasdaq
135
Offering
115
One
92
Partnership
76
Pharmaceuticals
136
Platform
66
Positive
63
Presentation
62
Program
91
Reach
135
Report
458
Research
183
Results
1014
Revenue
65
Sales
55
Services
74
Set
165
Solutions
83
Study
96
System
56
Technology
142
Therapeutics
269
Therapy
58
Treatment
104
Trial
115
Update
154
Year
274
Entities
Acumen pharmaceuticals inc
1
Alterity therapeutics limited
1
Amarin corporation plc
1
Argenx se
1
Arrowhead pharmaceuticals, inc.
1
Athira pharma, inc.
1
Atossa therapeutics, inc.
1
Biorestorative therapies, inc.
1
Brainsway ltd.
1
Century therapeutics inc
1
Cerevel therapeutics holdings, inc.
1
Charles river laboratories international, inc.
1
Chemomab therapeutics ltd - adr
1
Cognition therapeutics inc
2
Eli lilly and company
1
Evogene ltd.
1
First wave biopharma, inc.
1
Freeline therapeutics holdings plc
1
Gain therapeutics inc
1
Genedx holdings corp - class a
1
Icad inc.
1
Intelgenx technologies corp.
1
Johnson & johnson
2
Kodiak sciences inc
1
Laboratory corporation of america holdings
1
Longeveron llc - class a
1
Medtronic plc
1
Neurosense therapeutics ltd.
2
Newamsterdam pharma co b.v.
1
Ocugen, inc.
1
Olink holding ab (publ) - adr
1
Omniab inc
1
Opko health, inc.
1
Opthea limited
1
Outlook therapeutics, inc.
1
Pfizer, inc.
1
Posco
1
Quest diagnostics incorporated
1
Sage therapeutics, inc.
1
Silo pharma, inc.
1
Solid biosciences inc.
1
Takeda pharmaceutical company limited
1
Vertex pharmaceuticals incorporated
1
Werewolf therapeutics inc
1
Zevra therapeutics, inc.
1
Symbols
ABOS
1
AMRN
1
ARGX
1
ARWR
1
ATHA
1
ATHE
1
ATOS
1
BRSYF
1
BRTX
1
BWAY
1
CERE
1
CGTX
2
CMMB
1
CRL
1
DGX
1
EVGN
1
FRLN
1
FWBI
1
GANX
1
HOWL
1
ICAD
1
IGXT
1
IPSC
1
JNJ
2
KOD
1
LGVN
1
LH
1
LLY
1
MDT
1
NAMS
1
NRSN
2
OABI
1
OCGN
1
OLK
1
OPK
1
OPT
1
OTLK
1
PFE
1
PKX
1
SAGE
1
SILO
1
SILOD
1
SLDB
1
TAK
1
VRTX
1
WGS
1
ZVRA
1
Exchanges
Nasdaq
36
Nyse
9
Crawled Date
2024 - 04 - 24
5
2024 - 04 - 23
2
2024 - 04 - 22
3
2024 - 04 - 18
3
2024 - 04 - 17
2
2024 - 04 - 16
1
2024 - 04 - 15
3
2024 - 04 - 11
4
2024 - 04 - 10
1
2024 - 04 - 09
5
2024 - 04 - 08
3
2024 - 04 - 07
1
2024 - 04 - 06
1
2024 - 04 - 05
1
2024 - 04 - 04
2
2024 - 04 - 02
1
2024 - 04 - 01
5
Crawled Time
01:00
1
05:00
2
11:00
7
12:00
13
12:20
1
12:30
2
13:00
5
14:00
2
16:00
1
17:00
1
20:00
1
20:20
1
21:00
2
22:00
3
23:00
1
Source
alteritytherapeutics.com
1
neurosense.investorroom.com
1
www.biospace.com
9
www.globenewswire.com
27
www.prnewswire.com
5
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
published :
This month
tags :
Disease
save search
Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 | DelveInsight
Published:
2024-04-24
(Crawled : 22:00)
- prnewswire.com
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
OTLK
|
News
P
|
$8.2
0.0%
240K
|
Health Technology
|
Email alert
Add to watchlist
KOD
|
News
|
$3.37
1.2%
1.19%
340K
|
Health Technology
|
Email alert
Add to watchlist
OPT
|
News
|
$3.46
2.98%
2.89%
8.2K
|
Health Technology
|
Email alert
Add to watchlist
disease
market
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published:
2024-04-24
(Crawled : 20:00)
- globenewswire.com
FRLN
|
$6.48
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
disease
cell
meeting
parkinson’s
therapy
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
Published:
2024-04-24
(Crawled : 14:00)
- biospace.com/
ARWR
|
$23.285
-2.08%
-2.13%
810K
|
Health Technology
|
0.0%
|
O:
-0.76%
H:
0.0%
C:
0.0%
disease
kidney
treatment
pharmaceuticals
for
study
Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease
Published:
2024-04-24
(Crawled : 13:00)
- globenewswire.com
GANX
|
$3.16
-6.78%
-7.28%
150K
|
Professional, Scientific, and T...
|
0.0%
|
O:
-0.29%
H:
0.0%
C:
0.0%
gt-0228
disease
positive
for
parkinson’s
trial
therapeutics
therapy
results
First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients
Published:
2024-04-24
(Crawled : 11:00)
- globenewswire.com
FWBI
|
$3.04
-2.56%
-2.63%
37K
|
Manufacturing
|
5.05%
|
O:
-0.34%
H:
0.0%
C:
0.0%
first
disease
biopharma
for
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
Published:
2024-04-23
(Crawled : 12:30)
- globenewswire.com
WGS
|
$11.82
-1.5%
-1.52%
180K
|
Professional, Scientific, and T...
|
22.82%
|
O:
4.71%
H:
22.87%
C:
17.3%
partnership
rare
disease
health
Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
Published:
2024-04-23
(Crawled : 12:00)
- globenewswire.com
HOWL
|
$6.405
-0.54%
-0.55%
82K
|
Professional, Scientific, and T...
|
7.33%
|
O:
2.17%
H:
5.06%
C:
5.06%
il-10
first
disease
preclinical
for
meeting
therapeutics
potential
therapy
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease
Published:
2024-04-22
(Crawled : 14:00)
- biospace.com/
DGX
|
News
|
$137.55
0.62%
0.0%
1.6M
|
Health Services
|
6.43%
|
O:
0.33%
H:
0.0%
C:
0.0%
disease
services
biomarker
blood
risk
alzheimer's
diagnostics
NeuroSense and Genetika+ Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer's Disease
Published:
2024-04-22
(Crawled : 13:00)
- biospace.com/
NRSN
|
News
|
$1.33
-2.21%
-2.26%
130K
|
|
-4.23%
|
O:
-1.41%
H:
2.86%
C:
-3.57%
precision
disease
ongoing
alzheimer's
collaboration
trial
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease
Published:
2024-04-22
(Crawled : 12:00)
- globenewswire.com
CGTX
|
News
|
$2.0
0.0%
110K
|
|
8.7%
|
O:
-2.17%
H:
7.78%
C:
3.33%
disease
alzheimer’s
treat
for
therapeutics
platform
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Published:
2024-04-18
(Crawled : 23:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
1.48%
|
O:
0.0%
H:
0.0%
C:
0.0%
entyvio
fda
disease
active
for
therapy
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
Published:
2024-04-18
(Crawled : 11:00)
- globenewswire.com
CERE
|
$41.87
-0.29%
-0.29%
630K
|
Finance
|
1.02%
|
O:
0.78%
H:
0.0%
C:
0.0%
disease
positive
for
topline
parkinson’s
trial
therapeutics
results
living
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis
Published:
2024-04-18
(Crawled : 11:00)
- globenewswire.com
CMMB
|
$0.67
0.02%
3.4K
|
Manufacturing
|
2.92%
|
O:
-3.38%
H:
0.0%
C:
0.0%
ccl24
disease
association
publication
sclerosis
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
Published:
2024-04-17
(Crawled : 12:00)
- biospace.com/
SAGE
|
$14.0
8.11%
7.5%
2.3M
|
Health Technology
|
-15.08%
|
O:
-15.02%
H:
3.55%
C:
-3.01%
sage-718
disease
treatment
topline
parkinson’s
therapeutics
results
study
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
Published:
2024-04-17
(Crawled : 01:00)
- alteritytherapeutics.com
ATHE
|
$2.33
9.39%
8.58%
170K
|
Health Technology
|
3.9%
|
O:
0.0%
H:
7.32%
C:
-1.95%
disease
neurology
system
meeting
parkinson’s
therapeutics
argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease
Published:
2024-04-16
(Crawled : 05:00)
- globenewswire.com
ARGX
|
$375.0
-0.02%
-0.02%
200K
|
Health Technology
|
-1.12%
|
O:
-5.0%
H:
4.19%
C:
2.86%
disease
vyvgart
for
Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting
Published:
2024-04-15
(Crawled : 21:00)
- globenewswire.com
ZVRA
|
$4.57
-0.22%
-0.22%
160K
|
n/a
|
-4.28%
|
O:
1.15%
H:
1.03%
C:
-1.45%
disease
treatment
for
meeting
therapeutics
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
Published:
2024-04-15
(Crawled : 13:00)
- globenewswire.com
LGVN
4 d
|
$1.73
-4.95%
-5.2%
300K
|
|
7.69%
|
O:
41.42%
H:
42.68%
C:
22.59%
conference
disease
association
alzheimer’s
presentation
international
research
for
trial
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics
Published:
2024-04-15
(Crawled : 13:00)
- biospace.com/
OABI
|
News
|
$4.56
-1.72%
-1.75%
560K
|
|
-8.12%
|
O:
-1.58%
H:
1.77%
C:
-0.4%
drug
liver
disease
antibody
for
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
Published:
2024-04-11
(Crawled : 11:00)
- globenewswire.com
IPSC
|
$2.98
-4.79%
-5.03%
130K
|
Professional, Scientific, and T...
|
-18.49%
|
O:
3.39%
H:
11.53%
C:
2.02%
disease
million
pipeline
acquisition
expansion
therapeutics
← Previous
1
2
3
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.